Trial for controversial China-made Alzheimer’s drug aborted as capital raise hits snag, COVID hurts sales – FiercePharma Written by admin on May 14, 2022. Posted in News Feed Trial for controversial China-made Alzheimer’s drug aborted as capital raise hits snag, COVID hurts sales FiercePharma Go to News Source
